Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Possible conserved lipoprotein LpqK | 0.0031 | 0.0062 | 0.0181 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0121 | 0.1926 | 1 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0247 | 0.4527 | 0.9981 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0248 | 0.4536 | 1 |
Wolbachia endosymbiont of Brugia malayi | dUTPase | 0.0079 | 0.1065 | 1 |
Trypanosoma cruzi | importin beta-1 subunit, putative | 0.0039 | 0.0236 | 0.039 |
Entamoeba histolytica | deoxyuridine 5-triphosphate nucleotidohydrolase domain containing protein | 0.0079 | 0.1065 | 0.2347 |
Entamoeba histolytica | hypothetical protein | 0.0052 | 0.0498 | 0.1099 |
Mycobacterium tuberculosis | Probable lipase LipE | 0.0031 | 0.0062 | 0.0181 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0248 | 0.4536 | 1 |
Onchocerca volvulus | 0.0031 | 0.0062 | 0.5 | |
Toxoplasma gondii | deoxyuridine 5'-triphosphate nucleotidohydrolase, putative | 0.0079 | 0.1065 | 1 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0031 | 0.0062 | 0.0323 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0248 | 0.4536 | 1 |
Echinococcus multilocularis | snurportin 1 | 0.0513 | 1 | 1 |
Toxoplasma gondii | HEAT repeat-containing protein | 0.0048 | 0.0424 | 0.3604 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.1954 | 0.1903 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0248 | 0.4536 | 1 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0247 | 0.4527 | 0.9981 |
Mycobacterium tuberculosis | Conserved protein | 0.0031 | 0.0062 | 0.0181 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0248 | 0.4536 | 1 |
Brugia malayi | RNA, U transporter 1 | 0.0137 | 0.2248 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0052 | 0.0498 | 0.1099 |
Trypanosoma cruzi | thymidine kinase, putative | 0.0247 | 0.4527 | 1 |
Mycobacterium tuberculosis | Probable hydrolase | 0.0031 | 0.0062 | 0.0181 |
Trichomonas vaginalis | importin beta-1, putative | 0.0039 | 0.0236 | 0.0389 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0248 | 0.4536 | 1 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.0513 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.0236 | 0.0521 |
Trichomonas vaginalis | Importin beta-1 subunit, putative | 0.0039 | 0.0236 | 0.0389 |
Trypanosoma brucei | importin beta-1 subunit, putative | 0.0048 | 0.0424 | 0.0809 |
Trichomonas vaginalis | deoxyuridine 5'-triphosphate nucleotidohydrolase, putative | 0.0079 | 0.1065 | 0.2241 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0424 | 0.0364 |
Leishmania major | thymidine kinase, putative | 0.0247 | 0.4527 | 1 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0248 | 0.4536 | 1 |
Chlamydia trachomatis | deoxyuridine 5'-triphosphate nucleotidohydrolase | 0.0079 | 0.1065 | 1 |
Trypanosoma cruzi | thymidine kinase, putative | 0.0247 | 0.4527 | 1 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0031 | 0.0062 | 0.0323 |
Plasmodium falciparum | deoxyuridine 5'-triphosphate nucleotidohydrolase | 0.0079 | 0.1065 | 1 |
Echinococcus multilocularis | muscleblind protein | 0.0122 | 0.1954 | 0.1903 |
Mycobacterium leprae | Probable lipase LipE | 0.0031 | 0.0062 | 0.0323 |
Echinococcus granulosus | importin subunit beta 1 | 0.0048 | 0.0424 | 0.0364 |
Mycobacterium tuberculosis | Conserved protein | 0.0031 | 0.0062 | 0.0181 |
Plasmodium vivax | importin-beta 2, putative | 0.0048 | 0.0424 | 0.3604 |
Entamoeba histolytica | deoxyuridine 5-triphosphate nucleotidohydrolase, mitochondrial precursor, putative | 0.0079 | 0.1065 | 0.2347 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0195 | 0.3449 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0122 | 0.1954 | 0.1903 |
Mycobacterium leprae | conserved hypothetical protein | 0.0031 | 0.0062 | 0.0323 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0248 | 0.4536 | 1 |
Entamoeba histolytica | thymidine kinase, putative | 0.0247 | 0.4527 | 0.9981 |
Entamoeba histolytica | deoxyuridine 5-triphosphate nucleotidohydrolase domain containing protein | 0.0079 | 0.1065 | 0.2347 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0121 | 0.1926 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0248 | 0.4536 | 1 |
Entamoeba histolytica | deoxyuridine 5-triphosphate nucleotidohydrolase, mitochondrial precursor, putative | 0.0079 | 0.1065 | 0.2347 |
Schistosoma mansoni | importin beta-1 | 0.0048 | 0.0424 | 0.0364 |
Mycobacterium tuberculosis | Probable lipase LipD | 0.0031 | 0.0062 | 0.0181 |
Brugia malayi | Importin beta-1 subunit | 0.0048 | 0.0424 | 0.1653 |
Echinococcus granulosus | dUTP pyrophosphatase | 0.0079 | 0.1065 | 0.1009 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.1954 | 0.1903 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0248 | 0.4536 | 1 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0121 | 0.1926 | 0.5584 |
Mycobacterium tuberculosis | Conserved protein | 0.0031 | 0.0062 | 0.0181 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0248 | 0.4536 | 1 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0248 | 0.4536 | 1 |
Plasmodium vivax | deoxyuridine 5'-triphosphate nucleotidohydrolase, putative | 0.0079 | 0.1065 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0079 | 0.1065 | 0.2347 |
Brugia malayi | Muscleblind-like protein | 0.0122 | 0.1954 | 0.8652 |
Leishmania major | importin beta-1 subunit, putative | 0.0039 | 0.0236 | 0.039 |
Mycobacterium tuberculosis | Probable esterase/lipase LipP | 0.0031 | 0.0062 | 0.0181 |
Schistosoma mansoni | deoxyuridine 5'-triphosphate nucleotidohydrolase | 0.0079 | 0.1065 | 0.1009 |
Trichomonas vaginalis | Importin beta-1 subunit, putative | 0.0039 | 0.0236 | 0.0389 |
Mycobacterium ulcerans | hypothetical protein | 0.0031 | 0.0062 | 0.0323 |
Mycobacterium ulcerans | lipase LipD | 0.0031 | 0.0062 | 0.0323 |
Mycobacterium tuberculosis | Probable esterase LipL | 0.0031 | 0.0062 | 0.0181 |
Entamoeba histolytica | deoxyuridine 5-triphosphate nucleotidohydrolase domain containing protein | 0.0079 | 0.1065 | 0.2347 |
Trypanosoma brucei | importin beta-1 subunit, putative | 0.0048 | 0.0424 | 0.0809 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0247 | 0.4527 | 0.9981 |
Entamoeba histolytica | hypothetical protein | 0.0079 | 0.1065 | 0.2347 |
Mycobacterium tuberculosis | Probable conserved lipoprotein | 0.0031 | 0.0062 | 0.0181 |
Schistosoma mansoni | hypothetical protein | 0.0513 | 1 | 1 |
Echinococcus multilocularis | dUTP pyrophosphatase | 0.0079 | 0.1065 | 0.1009 |
Onchocerca volvulus | 0.0031 | 0.0062 | 0.5 | |
Brugia malayi | dUTP diphosphatase | 0.0079 | 0.1065 | 0.4586 |
Loa Loa (eye worm) | dUTP diphosphatase | 0.0079 | 0.1065 | 0.1009 |
Mycobacterium ulcerans | beta-lactamase | 0.0031 | 0.0062 | 0.0323 |
Echinococcus multilocularis | importin subunit beta 1 | 0.0048 | 0.0424 | 0.0364 |
Onchocerca volvulus | 0.0031 | 0.0062 | 0.5 | |
Trypanosoma brucei | thymidine kinase | 0.0247 | 0.4527 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0122 | 0.1954 | 0.1903 |
Entamoeba histolytica | deoxyuridine 5-triphosphate nucleotidohydrolase domain containing protein | 0.0079 | 0.1065 | 0.2347 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Average weight (functional) | = 2 % | antineoplastic activity on the survival time of mice bearing L1210 leukemia. Average weight change of mice from onset to termination of drug treatment. | ChEMBL. | 7473550 |
Average weight (functional) | = 2 % | antineoplastic activity on the survival time of mice bearing L1210 leukemia. Average weight change of mice from onset to termination of drug treatment. | ChEMBL. | 7473550 |
Average weight (functional) | = 6.8 % | antineoplastic activity on the survival time of mice bearing L1210 leukemia. Average weight change of mice from onset to termination of drug treatment. | ChEMBL. | 7473550 |
Average weight (functional) | = 6.8 % | antineoplastic activity on the survival time of mice bearing L1210 leukemia. Average weight change of mice from onset to termination of drug treatment. | ChEMBL. | 7473550 |
Average weight (functional) | = 7.3 % | antineoplastic activity on the survival time of mice bearing L1210 leukemia. Average weight change of mice from onset to termination of drug treatment. | ChEMBL. | 7473550 |
Average weight (functional) | = 7.3 % | antineoplastic activity on the survival time of mice bearing L1210 leukemia. Average weight change of mice from onset to termination of drug treatment. | ChEMBL. | 7473550 |
Dose (functional) | = 10 mg kg-1 | antineoplastic activity on the survival time of mice bearing L1210 leukemia. Daily dosage of the compound. | ChEMBL. | 7473550 |
Dose (functional) | = 10 mg kg-1 | antineoplastic activity on the survival time of mice bearing L1210 leukemia. Daily dosage of the compound. | ChEMBL. | 7473550 |
Dose (functional) | = 20 mg kg-1 | antineoplastic activity on the survival time of mice bearing L1210 leukemia. Daily dosage of the compound. | ChEMBL. | 7473550 |
Dose (functional) | = 20 mg kg-1 | antineoplastic activity on the survival time of mice bearing L1210 leukemia. Daily dosage of the compound. | ChEMBL. | 7473550 |
Dose (functional) | = 40 mg kg-1 | antineoplastic activity on the survival time of mice bearing L1210 leukemia. Daily dosage of the compound. | ChEMBL. | 7473550 |
Dose (functional) | = 40 mg kg-1 | antineoplastic activity on the survival time of mice bearing L1210 leukemia. Daily dosage of the compound. | ChEMBL. | 7473550 |
T/C (functional) | = 138 % | antineoplastic activity on the survival time of mice bearing L1210 leukemia.% T/C represents the ratio of the survival time of treated to control mice * 100. | ChEMBL. | 7473550 |
T/C (functional) | = 138 % | antineoplastic activity on the survival time of mice bearing L1210 leukemia.% T/C represents the ratio of the survival time of treated to control mice * 100. | ChEMBL. | 7473550 |
T/C (functional) | = 141 % | antineoplastic activity on the survival time of mice bearing L1210 leukemia.% T/C represents the ratio of the survival time of treated to control mice * 100. | ChEMBL. | 7473550 |
T/C (functional) | = 141 % | antineoplastic activity on the survival time of mice bearing L1210 leukemia.% T/C represents the ratio of the survival time of treated to control mice * 100. | ChEMBL. | 7473550 |
T/C (functional) | = 149 % | antineoplastic activity on the survival time of mice bearing L1210 leukemia.% T/C represents the ratio of the survival time of treated to control mice * 100. | ChEMBL. | 7473550 |
T/C (functional) | = 149 % | antineoplastic activity on the survival time of mice bearing L1210 leukemia.% T/C represents the ratio of the survival time of treated to control mice * 100. | ChEMBL. | 7473550 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.